Part of the Pemphigus & Bullous Disorders Knowledge Library
There is no clinic visit in EPOH. Not at intake, not at review, not at the end. There is no procedure, no in-clinic therapy, and no treatment room you will ever sit in.
The protocol is oral formulations and home-applied topicals, couriered to your address and taken by you at home. That is the whole delivery mechanism, and it does not have an exception.
This surprises people, and a fair number are suspicious of it — reasonably, since "no need to come in" is also what a certain kind of operation says. So this page is the argument for it, and the honest account of what it costs you.
The obvious reading is that a remote model is a convenience we are dressing up as a principle. Cheaper for us, so we call it a feature.
The actual reason is narrower. Nothing in this protocol requires your body to be in a room. There is no therapy to administer. The intervention is a set of compounds and an order in which to take them. If there is nothing to be done to you, then requiring you to travel is not clinical rigour. It is theatre with a travel cost attached.
And in this specific disease, the travel cost is not trivial.
Pemphigoid is overwhelmingly a disease of older people. Many of the people reading this are in their seventies or eighties, and a proportion are frail. Their skin blisters, and blistered skin fails under shear — the friction of being helped into a car, of a seatbelt, of a waiting-room chair, of being transferred from one surface to another. An intact blister that would have survived the day at home may not survive the journey. Every trip is an opportunity for mechanical trauma to skin that is already failing at its adhesion, and mechanical trauma is not neutral in a blistering disease.
Then there is infection. Open erosions are a breach in the body's largest barrier, in a patient who is very often on systemic immunosuppression. A waiting room in the middle of a respiratory season is not a good place for that person to spend an hour.
And for pemphigus vulgaris, where the mouth is usually the first site and sometimes the worst: the patient with raw erosions across the buccal mucosa, who cannot eat and finds swallowing painful, is not someone for whom a two-hour journey is a neutral event.
The people this disease selects are precisely the people least able to absorb the cost of attending. That is the argument. It is not that remote care is somehow superior to being seen. It is that for this protocol there is nothing to attend, and pretending otherwise would impose a real risk for no clinical return.
Not nothing. The assessment is longer than most in-person intakes, and considerably more document-heavy.
We want the biopsy report, and critically the direct immunofluorescence result. DIF is what actually establishes an autoimmune blistering diagnosis. A clinical impression is not a substitute for it, and neither is a photograph.
We want ELISA titres where your dermatologist has run them: BP180 and BP230 for pemphigoid; desmoglein 1 and desmoglein 3 for pemphigus. Those titres track disease activity, and they are the closest thing to an objective number this field has.
We want photographs, taken to a protocol: same light, same distance, same sites, weekly, with a size reference in frame.
We want the daily diary: new blister count, itch score, erosion healing time, mucosal function.
And we want the full drug list, the gut history, the sleep history, and an account of what was happening in your life in the months before the first lesion.
Reviews are by call, on a schedule, against the diary. Formulations are revised and re-couriered as the phase changes.
We cannot examine you.
That is not a soft limitation to be waved past. It is the central one, and you should hold it clearly.
We cannot palpate a lesion. We cannot elicit a Nikolsky sign — the shearing of apparently normal skin under lateral pressure, which is a genuine and useful clinical finding in pemphigus, and which requires a hand. We cannot look inside your mouth, examine your conjunctiva, or assess a wound that may have become infected. We cannot reliably tell, from a photograph, the difference between a healing erosion and an early cellulitis, and we are not going to pretend that we can.
Which makes the following a structural requirement of the protocol rather than a disclaimer at the bottom of a page:
You must remain under a dermatologist.
Not as a formality. As the person who examines you, who scores your disease, who orders the titres, who owns the immunosuppression, who makes every taper decision, and who is there when something acute happens.
If you are not under a dermatologist, you are not a candidate for this protocol, and we would rather decline the case than accept it as your only clinical contact.
We are supportive care. That phrase does real work, and it is not modesty. It describes the exact limit of what a box in the post can be.
The remote model has one failure mode that worries us more than any other. Someone with an itch and a few blisters, no biopsy, no DIF, decides they have pemphigoid — and orders a protocol instead of making an appointment.
Do not do this.
The itch of pemphigoid precedes blistering by months and is routinely mistaken for eczema or scabies. Which means the reverse is equally true: eczema and scabies are routinely mistaken for pemphigoid by patients reading about it at night. Blistering conditions can also be drug-induced, infective, or something else entirely.
And if what you have is inherited epidermolysis bullosa — a genetic fault in the proteins that anchor skin, present from birth, not an autoimmune disease at all — then nothing in this protocol and nothing in any other will alter its course. Only epidermolysis bullosa acquisita is autoimmune, and telling the two apart is a job for a biopsy, not for a search engine.
The diagnosis comes first, from a dermatologist, with a biopsy and immunofluorescence. There is no remote substitute for that, and we are not offering one.
Because we cannot see you, you need to know exactly what to take elsewhere without waiting for a scheduled call:
Rapidly spreading blistering. An erosion with spreading redness, pus, odour, fever, or pain out of proportion to the wound. New mouth or throat erosions, or an inability to eat or drink. Fever or systemic illness in an immunosuppressed person.
And any eye symptom whatsoever — grittiness, redness, a foreign-body sensation, a lash turning inward. Mucous membrane pemphigoid scars the conjunctiva, and conjunctival scarring is sight-threatening. That is an ophthalmology emergency the same day.
None of those is a thing a box in the post can address. We are not going to be the reason you waited.
There is no clinic visit because there is nothing in this protocol that requires one, and because the patients this disease selects are the ones for whom attending is most costly and most risky.
The price of that is that we never see you. We have accepted that price by insisting that somebody else does — your dermatologist, throughout, without interruption.
If you were hoping this would replace them, it will not. This is the page where we would rather lose you than mislead you.
Medical disclaimer. This article is for general information and is not a substitute for personalised medical advice. Ayurvedic treatment at EliteAyurveda is individualised following clinical assessment. Do not start, stop or alter any prescribed medication without consulting your treating physician.